EBS icon

Emergent Biosolutions
EBS

Overview Fund Activity

297 hedge funds and large institutions have $2.53B invested in Emergent Biosolutions in 2018 Q4 according to their latest regulatory filings, with 55 funds opening new positions, 106 increasing their positions, 105 reducing their positions, and 31 closing their positions.

Holders
297
Holders Change
+22
Holders Change %
+8%
% of All Funds
6.63%
Holding in Top 10
4
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.09%
New
55
Increased
106
Reduced
105
Closed
31
Calls
$3.06M
Puts
$1.1M
Net Calls
+$1.97M
Net Calls Change
+$965K

Top Buyers

1
Neuberger Berman Group
1
Neuberger Berman Group
New York
$77.3M
2
VOYA Investment Management
2
VOYA Investment Management
Georgia
$21.9M
3
Lord, Abbett & Co
3
Lord, Abbett & Co
New Jersey
$18.2M
4
ACM
4
Atlanta Capital Management
Georgia
$15.6M
5
FA
5
Friess Associates
Delaware
$15.2M

Top Sellers

1
Acadian Asset Management
1
Acadian Asset Management
Massachusetts
$55.3M
2
Aberdeen Group
2
Aberdeen Group
United Kingdom
$46.1M
3
Royal Bank of Canada
3
Royal Bank of Canada
Ontario, Canada
$38.2M
4
Renaissance Technologies
4
Renaissance Technologies
New York
$94.6M
5
Goldman Sachs
5
Goldman Sachs
New York
$47.2M
Name Market Value Shares Shares
Change 		Shares
Change %
WSTAM
326
Wilbanks Smith & Thomas Asset Management
Virginia
– – -23 Closed
CAG
327
Csenge Advisory Group
Florida
– – -14 Closed
Simplex Trading
328
Simplex Trading
Illinois
– – – –
Susquehanna International Group
329
Susquehanna International Group
Pennsylvania
– – – –
Wolverine Trading
330
Wolverine Trading
Illinois
– – – –
PFGIA
331
Patriot Financial Group Insurance Agency
Massachusetts
$0 5 +5 New
10 11 12 13
14